Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Prepublished online as a Blood First Edition Paper on May 13, 2002; DOI 10.1182/blood-2002-01-0151.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2002-01-0151v1
100/5/1828    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mori, N.
Right arrow Articles by Fujii, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mori, N.
Right arrow Articles by Fujii, M.
Related Collections
Right arrow Signal Transduction
Right arrow Neoplasia
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, 1 September 2002, Vol. 100, No. 5, pp. 1828-1834

NEOPLASIA

Bay 11-7082 inhibits transcription factor NF-kappa B and induces apoptosis of HTLV-I-infected T-cell lines and primary adult T-cell leukemia cells

Naoki Mori, Yasuaki Yamada, Shuichi Ikeda, Yoshihiro Yamasaki, Kunihiro Tsukasaki, Yuetsu Tanaka, Masao Tomonaga, Naoki Yamamoto, and Masahiro Fujii

From the Department of Preventive Medicine and AIDS Research, Institute of Tropical Medicine, Nagasaki University, Japan; the Department of Hematology, Molecular Medicine Unit, Atomic Bomb Disease Institute, and the Department of Laboratory Medicine, Nagasaki University School of Medicine, Japan; the Department of Internal Medicine, Sasebo City General Hospital, Japan; the Department of Internal Medicine, Kokura Memorial Hospital, Kitakyushu, Japan; the Department of Infectious Disease and Immunology, Okinawa-Asia Research Center of Medical Science, Faculty of Medicine, University of the Ryukyus, Nishihara, Okinawa, Japan; and the Division of Virology, Niigata University Graduate School of Medicine and Dental Sciences, Japan.

Human T-cell leukemia virus type I (HTLV-I) is the causative agent of an aggressive form of leukemia designated adult T-cell leukemia (ATL). We have previously demonstrated that all T-cell lines infected with HTLV-I and primary leukemic cells from ATL patients display constitutively high activity of transcription factor NF-kappa B. In this study we showed that Bay 11-7082, an inhibitor of NF-kappa B, induced apoptosis of HTLV-I-infected T-cell lines but only negligible apoptosis of HTLV-I-negative T cells. Bay 11-7082 rapidly and efficiently reduced the DNA binding of NF-kappa B in HTLV-I-infected T-cell lines and down-regulated the expression of the antiapoptotic gene, Bcl-xL, regulated by NF-kappa B, whereas it had little effect on the DNA binding of another transcription factor, AP-1. Although the viral protein Tax is an activator of NF-kappa B, Bay 11-7082-induced apoptosis of HTLV-I-infected cells was not associated with reduced expression of Tax. Furthermore, Bay 11-7082- induced apoptosis of primary ATL cells was more prominent than that of normal peripheral blood mononuclear cells, and apoptosis of these cells was also associated with down-regulation of NF-kappa B activity. Our results indicate that NF-kappa B plays a crucial role in the pathogenesis and survival of HTLV-I-infected leukemic cells and that it is a suitable target for the prevention and treatment of ATL.

© 2002 by The American Society of Hematology.
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
Y. Saitoh, N. Yamamoto, M. Z. Dewan, H. Sugimoto, V. J. Martinez Bruyn, Y. Iwasaki, K. Matsubara, X. Qi, T. Saitoh, I. Imoto, et al.
Overexpressed NF-{kappa}B-inducing kinase contributes to the tumorigenesis of adult T-cell leukemia and Hodgkin Reed-Sternberg cells
Blood, May 15, 2008; 111(10): 5118 - 5129.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
N. Shembade, N. S. Harhaj, M. Yamamoto, S. Akira, and E. W. Harhaj
The Human T-Cell Leukemia Virus Type 1 Tax Oncoprotein Requires the Ubiquitin-Conjugating Enzyme Ubc13 for NF-{kappa}B Activation
J. Virol., December 15, 2007; 81(24): 13735 - 13742.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
C. M. Alvira, A. Abate, G. Yang, P. A. Dennery, and M. Rabinovitch
Nuclear Factor-{kappa}B Activation in Neonatal Mouse Lung Protects against Lipopolysaccharide-induced Inflammation
Am. J. Respir. Crit. Care Med., April 15, 2007; 175(8): 805 - 815.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. J. Jost and J. Ruland
Aberrant NF-{kappa}B signaling in lymphoma: mechanisms, consequences, and therapeutic implications
Blood, April 1, 2007; 109(7): 2700 - 2707.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. C. Ramos, P. Ruiz Jr, L. Ratner, I. M. Reis, C. Brites, C. Pedroso, G. E. Byrne Jr, N. L. Toomey, V. Andela, E. W. Harhaj, et al.
IRF-4 and c-Rel expression in antiviral-resistant adult T-cell leukemia/lymphoma
Blood, April 1, 2007; 109(7): 3060 - 3068.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
S. Shimizu, M. Tahara, S. Ogata, K. Hashimoto, K. Morishige, K. Tasaka, and Y. Murata
Involvement of nuclear factor-kB activation through RhoA/Rho-kinase pathway in LPS-induced IL-8 production in human cervical stromal cells
Mol. Hum. Reprod., March 1, 2007; 13(3): 181 - 187*.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Brown, M. Bellon, and C. Nicot
Emodin and DHA potently increase arsenic trioxide interferon-{alpha}-induced cell death of HTLV-I-transformed cells by generation of reactive oxygen species and inhibition of Akt and AP-1
Blood, February 15, 2007; 109(4): 1653 - 1659.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. S. Harhaj, S.-C. Sun, and E. W. Harhaj
Activation of NF-{kappa}B by the Human T Cell Leukemia Virus Type I Tax Oncoprotein Is Associated with Ubiquitin-dependent Relocalization of I{kappa}B Kinase
J. Biol. Chem., February 9, 2007; 282(6): 4185 - 4192.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. K. Kundu, Y. K. Shin, S. H. Kim, and Y.-J. Surh
Resveratrol inhibits phorbol ester-induced expression of COX-2 and activation of NF-{kappa}B in mouse skin by blocking I{kappa}B kinase activity
Carcinogenesis, July 1, 2006; 27(7): 1465 - 1474.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
X.-F. Che, C.-L. Zheng, S. Owatari, M. Mutoh, T. Gotanda, H.-C. Jeung, T. Furukawa, R. Ikeda, M. Yamamoto, M. Haraguchi, et al.
Overexpression of survivin in primary ATL cells and sodium arsenite induces apoptosis by down-regulating survivin expression in ATL cell lines
Blood, June 15, 2006; 107(12): 4880 - 4887.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Waldele, K. Silbermann, G. Schneider, T. Ruckes, B. R. Cullen, and R. Grassmann
Requirement of the human T-cell leukemia virus (HTLV-1) tax-stimulated HIAP-1 gene for the survival of transformed lymphocytes
Blood, June 1, 2006; 107(11): 4491 - 4499.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
T. Okudaira, M. Tomita, J.-N. Uchihara, T. Matsuda, C. Ishikawa, H. Kawakami, M. Masuda, Y. Tanaka, K. Ohshiro, N. Takasu, et al.
NIK-333 inhibits growth of human T-cell leukemia virus type I-infected T-cell lines and adult T-cell leukemia cells in association with blockade of nuclear factor-{kappa}B signal pathway.
Mol. Cancer Ther., March 1, 2006; 5(3): 704 - 712.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Z. Dewan, J.-n. Uchihara, K. Terashima, M. Honda, T. Sata, M. Ito, N. Fujii, K. Uozumi, K. Tsukasaki, M. Tomonaga, et al.
Efficient intervention of growth and infiltration of primary adult T-cell leukemia cells by an HIV protease inhibitor, ritonavir
Blood, January 15, 2006; 107(2): 716 - 724.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Watanabe, T. Ohsugi, M. Shoda, T. Ishida, S. Aizawa, M. Maruyama-Nagai, A. Utsunomiya, S. Koga, Y. Yamada, S. Kamihira, et al.
Dual targeting of transformed and untransformed HTLV-1-infected T cells by DHMEQ, a potent and selective inhibitor of NF-{kappa}B, as a strategy for chemoprevention and therapy of adult T-cell leukemia
Blood, October 1, 2005; 106(7): 2462 - 2471.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
C. K. Wong, P. F. Y. Cheung, W. K. Ip, and C. W. K. Lam
Interleukin-25-Induced Chemokines and Interleukin-6 Release from Eosinophils Is Mediated by p38 Mitogen-Activated Protein Kinase, c-Jun N-Terminal Kinase, and Nuclear Factor-{kappa}B
Am. J. Respir. Cell Mol. Biol., August 1, 2005; 33(2): 186 - 194.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
T. Ohsugi, R. Horie, T. Kumasaka, A. Ishida, T. Ishida, K. Yamaguchi, T. Watanabe, K. Umezawa, and T. Urano
In vivo antitumor activity of the NF-{kappa}B inhibitor dehydroxymethylepoxyquinomicin in a mouse model of adult T-cell leukemia
Carcinogenesis, August 1, 2005; 26(8): 1382 - 1388.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
T. Ikezoe, Y. Yang, K. Bandobashi, T. Saito, S. Takemoto, H. Machida, K. Togitani, H. P. Koeffler, and H. Taguchi
Oridonin, a diterpenoid purified from Rabdosia rubescens, inhibits the proliferation of cells from lymphoid malignancies in association with blockade of the NF-{kappa}B signal pathways
Mol. Cancer Ther., April 1, 2005; 4(4): 578 - 586.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
F. Larousserie, E. Bardel, S. Pflanz, B. Arnulf, C. Lome-Maldonado, O. Hermine, L. Bregeaud, M. Perennec, N. Brousse, R. Kastelein, et al.
Analysis of Interleukin-27 (EBI3/p28) Expression in Epstein-Barr Virus- and Human T-Cell Leukemia Virus Type 1-Associated Lymphomas: Heterogeneous Expression of EBI3 Subunit by Tumoral Cells
Am. J. Pathol., April 1, 2005; 166(4): 1217 - 1228.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. Sanda, S. Iida, H. Ogura, K. Asamitsu, T. Murata, K. B. Bacon, R. Ueda, and T. Okamoto
Growth Inhibition of Multiple Myeloma Cells by a Novel I{kappa}B Kinase Inhibitor
Clin. Cancer Res., March 1, 2005; 11(5): 1974 - 1982.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. Matsuda, A. Almasan, M. Tomita, J.-n. Uchihara, M. Masuda, K. Ohshiro, N. Takasu, H. Yagita, T. Ohta, and N. Mori
Resistance to Apo2 Ligand (Apo2L)/Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)-Mediated Apoptosis and Constitutive Expression of Apo2L/TRAIL in Human T-Cell Leukemia Virus Type 1-Infected T-Cell Lines
J. Virol., February 1, 2005; 79(3): 1367 - 1378.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. R. Jazirehi, S. Huerta-Yepez, G. Cheng, and B. Bonavida
Rituximab (Chimeric Anti-CD20 Monoclonal Antibody) Inhibits the Constitutive Nuclear Factor-{kappa}B Signaling Pathway in Non-Hodgkin's Lymphoma B-Cell Lines: Role in Sensitization to Chemotherapeutic Drug-induced Apoptosis
Cancer Res., January 1, 2005; 65(1): 264 - 276.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Devadas, N. J. Hardegen, L. M. Wahl, I. K. Hewlett, K. A. Clouse, K. M. Yamada, and S. Dhawan
Mechanisms for Macrophage-Mediated HIV-1 Induction
J. Immunol., December 1, 2004; 173(11): 6735 - 6744.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Vora, A. Youdim, L. S. Thomas, M. Fukata, S. Y. Tesfay, K. Lukasek, K. S. Michelsen, A. Wada, T. Hirayama, M. Arditi, et al.
{beta}-Defensin-2 Expression Is Regulated by TLR Signaling in Intestinal Epithelial Cells
J. Immunol., November 1, 2004; 173(9): 5398 - 5405.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. Zhang, Z.-N. Lin, C.-F. Yang, X. Shi, C.-N. Ong, and H.-M. Shen
Suppressed NF-{kappa}B and sustained JNK activation contribute to the sensitization effect of parthenolide to TNF-{alpha}-induced apoptosis in human cancer cells
Carcinogenesis, November 1, 2004; 25(11): 2191 - 2199.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
U. Sinha-Datta, I. Horikawa, E. Michishita, A. Datta, J. C. Sigler-Nicot, M. Brown, M. Kazanji, J. C. Barrett, and C. Nicot
Transcriptional activation of hTERT through the NF-{kappa}B pathway in HTLV-I-transformed cells
Blood, October 15, 2004; 104(8): 2523 - 2531.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S.-J. Jeong, M. Radonovich, J. N. Brady, and C. A. Pise-Masison
HTLV-I Tax induces a novel interaction between p65/RelA and p53 that results in inhibition of p53 transcriptional activity
Blood, September 1, 2004; 104(5): 1490 - 1497.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Luft, E. Maraskovsky, M. Schnurr, K. Knebel, M. Kirsch, M. Gorner, R. Skoda, A. D. Ho, P. Nawroth, and A. Bierhaus
Tuning the volume of the immune response: strength and persistence of stimulation determine migration and cytokine secretion of dendritic cells
Blood, August 15, 2004; 104(4): 1066 - 1074.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. Zhang, J. Zhu, A. Imrich, M. Cushion, T. B. Kinane, and H. Koziel
Pneumocystis Activates Human Alveolar Macrophage NF-{kappa}B Signaling through Mannose Receptors
Infect. Immun., June 1, 2004; 72(6): 3147 - 3160.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
N. Mori, T. Matsuda, M. Tadano, T. Kinjo, Y. Yamada, K. Tsukasaki, S. Ikeda, Y. Yamasaki, Y. Tanaka, T. Ohta, et al.
Apoptosis Induced by the Histone Deacetylase Inhibitor FR901228 in Human T-Cell Leukemia Virus Type 1-Infected T-Cell Lines and Primary Adult T-Cell Leukemia Cells
J. Virol., May 1, 2004; 78(9): 4582 - 4590.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Dai, X.-Y. Pei, M. Rahmani, D. H. Conrad, P. Dent, and S. Grant
Interruption of the NF-{kappa}B pathway by Bay 11-7082 promotes UCN-01-mediated mitochondrial dysfunction and apoptosis in human multiple myeloma cells
Blood, April 1, 2004; 103(7): 2761 - 2770.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. A. Guthridge, E. F. Barry, F. A. Felquer, B. J. McClure, F. C. Stomski, H. Ramshaw, and A. F. Lopez
The phosphoserine-585-dependent pathway of the GM-CSF/IL-3/IL-5 receptors mediates hematopoietic cell survival through activation of NF-{kappa}B and induction of bcl-2
Blood, February 1, 2004; 103(3): 820 - 827.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. E. Rusinol, D. Thewke, J. Liu, N. Freeman, S. R. Panini, and M. S. Sinensky
AKT/Protein Kinase B Regulation of BCL Family Members during Oxysterol-induced Apoptosis
J. Biol. Chem., January 9, 2004; 279(2): 1392 - 1399.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Mohapatra, B. Chu, S. Wei, J. Djeu, P. K. Epling-Burnette, T. Loughran, R. Jove, and W. J. Pledger
Roscovitine Inhibits STAT5 Activity and Induces Apoptosis in the Human Leukemia Virus Type 1-Transformed Cell Line MT-2
Cancer Res., December 1, 2003; 63(23): 8523 - 8530.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
H. J. Brown, M. J. Song, H. Deng, T.-T. Wu, G. Cheng, and R. Sun
NF-{kappa}B Inhibits Gammaherpesvirus Lytic Replication
J. Virol., August 1, 2003; 77(15): 8532 - 8540.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
N. Mori, A. M. Krensky, R. Geleziunas, A. Wada, T. Hirayama, C. Sasakawa, and N. Yamamoto
Helicobacter pylori Induces RANTES through Activation of NF-{kappa}B
Infect. Immun., July 1, 2003; 71(7): 3748 - 3756.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Z. Dewan, K. Terashima, M. Taruishi, H. Hasegawa, M. Ito, Y. Tanaka, N. Mori, T. Sata, Y. Koyanagi, M. Maeda, et al.
Rapid Tumor Formation of Human T-Cell Leukemia Virus Type 1-Infected Cell Lines in Novel NOD-SCID/{gamma}cnull Mice: Suppression by an Inhibitor against NF-{kappa}B
J. Virol., May 1, 2003; 77(9): 5286 - 5294.
[Abstract] [Full Text] [PDF]


Home page
Mol. Interv.Home page
S. C. Bunnell
Determining the Destiny of NF-{kappa} B after TCR Ligation: It's CARMA1
Mol. Interv., October 1, 2002; 2(6): 356 - 360.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
Sponsor: Genentech BioOncology and and Biogen Idec
Blood Online is supported in part by
Genentech BioOncology and Biogen Idec
  Copyright © 2002 by American Society of Hematology         Online ISSN: 1528-0020